Please login to the form below

Not currently logged in
Email:
Password:

Sanofi Pasteur begins dengue vaccine study

Sanofi Pasteur, the vaccines division of sanofi-aventis has announced it is to begin a paediatric clinical study to test the efficacy of its tetravalent vaccine for dengue fever

Sanofi Pasteur, the vaccines division of sanofi-aventis has announced it is to begin a paediatric clinical study to test the efficacy of its tetravalent vaccine for dengue fever.

The study will be carried out in Thailand in collaboration with Mahidol University of Thailand, the Ministry of Public Health, and the Paediatric Dengue Vaccine Initiative. The programme follows guidelines from the Initiative for Vaccine Research (IVR) led by the World Health Organisation (WHO).

"Large scale paediatric studies are instrumental for the development of a safe and efficacious dengue vaccine to protect against a disease that primarily affects children," said Dr Pratap Singhasivanon, dean of the faculty of tropical medicine, Mahidol University. "We are happy to contribute to an important milestone with the actual start of an efficacy study in Ratchaburi."

Dengue fever is the most widespread tropical disease after malaria. Carried by mosquitoes, the disease is a threat to almost half of the world's population.

18th February 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

We're award-winning joint working specialists. We help our clients to transform healthcare through effective collaboration, and deliver work to feel...

Latest intelligence

How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...
Medopad: the up and coming unicorn transforming remote patient monitoring
Blue Latitude Health speaks to Medopad’s Martha Carruthers to learn how the start-up’s modular apps are helping patients with complex diseases....

Infographics